Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2023-02-15 M&A Activity
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Biotage stärker sin position som en global ledare inom kromatografi genom det transformerande förvärvet av Astrea Bioseparations
M&A Activity Classification · 99% confidence The document is a press release announcing a significant corporate action: Biotage's agreement to acquire Astrea Bioseparations. Key indicators include: 1. The content focuses on the terms of the transaction (valuation, share issuance, capital contribution, lock-up agreements). 2. It explicitly mentions conditions requiring shareholder approval at the Annual General Meeting (AGM) on April 27, 2023, including a proposal for a new board structure. 3. The document is dated February 15, 2023, and is a formal announcement of a major corporate event, not a routine financial report (like 10-K or IR). 4. While it mentions the upcoming AGM and shareholder votes, the primary purpose is announcing the M&A deal itself, which involves capital changes (share issuance). 5. The closest fit among the provided codes for a major corporate transaction announcement involving financing/capital structure changes (share issuance as consideration) is 'Capital/Financing Update' (CAP) or potentially 'M&A Activity' (TAR). Since the core of the announcement details the financing structure (issuing shares as consideration) and the transaction's financial terms, CAP is highly relevant. However, TAR (M&A Activity) is specifically for merger proposals or takeover bids, which this acquisition clearly is. 6. Given the detailed description of the acquisition, the consideration structure (share issuance), and the strategic rationale, 'TAR' (M&A Activity) is the most precise classification for a document detailing a merger/acquisition agreement. 7. The document is not a short announcement linking to a report, so RPA/RNS is less appropriate than the specific transaction type.
2023-02-15 Swedish
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 99% confidence The document details changes in shareholding and voting rights for an issuer (Biotage AB) held by an entity (Invesco Ltd.). It explicitly shows the 'Before the transaction' and 'After the transaction' holdings, including the resulting percentage of voting rights (4.99745%). This structure is characteristic of a Major Shareholding Notification, where an investor reports crossing or moving within ownership thresholds. This aligns perfectly with the definition for 'Major Shareholding Notification' (MRQ). The document is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2022-11-24 English
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Biotage AB covering the period January to September 2022. It contains detailed financial statements, including income statements, cash flow data, and management commentary (VD har ordet). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-02 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report January - September 2022' for Biotage AB. It contains detailed financial statements, including net sales, operating profit, EBITA, and cash flow for the quarter and the nine-month period. It also includes a 'Message from the CEO' and a 'Financial overview' table. Since it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. 9M 2022
2022-11-02 English
Förändring i antal aktier och röster
Share Issue/Capital Change Classification · 98% confidence The document text is very short (2360 characters) and its primary content is an announcement regarding a change in the total number of shares and votes following the issuance of new C-shares as part of an incentive program (LTIP 2022). It explicitly states that the information is being made public ('Såsom tidigare offentliggjorts' and the final disclosure statement). The document does not contain the full details of a financial report (like 10-K or IR) but rather reports a specific corporate action related to capital structure (share issuance/change). This fits best under 'Share Issue/Capital Change' (SHA). It is not a general regulatory filing (RNS) because a more specific category exists, and it is not an announcement of a report publication (RPA) because it contains the core information itself, not just a pointer to another document.
2022-10-31 Swedish
Change in number of shares and votes
Share Issue/Capital Change Classification · 98% confidence The document explicitly details a change in the number of issued shares (class C shares) following an incentive program adopted at the AGM, resulting in an update to the total registered shares and votes. This directly relates to the company's capital structure and share count. This fits the definition of 'Share Issue/Capital Change' (SHA). It is not a general financing announcement (CAP) but a specific notification of an executed share issuance affecting the total count. Given the content, SHA is the most precise classification.
2022-10-31 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.